Profiles of subgingival microbiomes and gingival crevicular metabolic signatures in patients with amnestic mild cognitive impairment and Alzheimer's diseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This cross-sectional study characterized both the subgingival plaque microbiome and the gingival crevicular fluid (GCF) metabolome in people with Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI). It tested the oral-brain axis idea linking periodontitis to AD. Subgingival plaque was profiled with 16S rRNA sequencing on the PacBio platform. GCF metabolites were measured by LC-MS/MS untargeted metabolomics. Multiomics DIABLO analysis integrated microbes and metabolites to find markers tracking cognitive decline.
Who was studied?
The cohort was 96 adults in Shanghai, China: 32 with AD, 32 with aMCI, and 32 cognitively normal controls. AD cases spanned 8 mild, 17 moderate, and 7 severe by MMSE. Diagnoses followed National Institute on Aging and Alzheimer's Association criteria, supported by MRI. Participants needed at least six functional teeth and no recent periodontal treatment, diabetes, or antibiotics. All subjects underwent standardized neurological and full-mouth periodontal examinations, sampling subgingival plaque and GCF.
What were the most important findings?
Periodontitis severity was significantly higher in AD than in aMCI or controls, with greater clinical attachment loss and bleeding. Beta diversity differed significantly among groups, though alpha diversity did not. MaAsLin2 linked 16 subgingival species to cognitive function, and 165 GCF metabolites differed among groups. DIABLO integration tied 19 differentially abundant metabolites to five subgingival species. GCF metabolites galactinol, sn-glycerol 3-phosphoethanolamine, D-mannitol, L-iditol, and an indole compound distinguished AD with high accuracy (AUC above 0.98).
What are the greatest implications of this study?
The findings support the oral-brain axis hypothesis, suggesting periodontal dysbiosis and altered gingival metabolism may accompany AD progression and could serve as noninvasive markers. The authors stress correlation, not proven causation. GCF is anatomically close to cerebrospinal fluid, making it an attractive, accessible source for potential biomarkers of cognitive status. Because the study is cross-sectional with control groups younger than AD patients and an uneven sex balance, the diagnostic accuracy may be inflated. Larger age- and sex-matched longitudinal cohorts are needed.